Annual Long Term Debt
$42.24 M
-$9.13 M-17.77%
December 31, 2022
Summary
- As of February 10, 2025, ORTX annual long term debt is $42.24 million, with the most recent change of -$9.13 million (-17.77%) on December 31, 2022.
- During the last 3 years, ORTX annual long term debt has risen by +$2.22 million (+5.54%).
Performance
ORTX Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Long Term Debt
$32.84 M
-$1.64 M-4.76%
September 30, 2023
Summary
- As of February 10, 2025, ORTX quarterly long term debt is $32.84 million, with the most recent change of -$1.64 million (-4.76%) on September 30, 2023.
- Over the past year, ORTX quarterly long term debt has dropped by -$11.51 million (-25.94%).
Performance
ORTX Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
ORTX Long Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -17.8% | -25.9% |
| 3 y3 years | +5.5% | -29.2% |
| 5 y5 years | - | - |
ORTX Long Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -17.8% | at low | -36.1% | at low |
| 5 y | 5-year | -17.8% | -5.3% | -38.4% | at low |
| alltime | all time | -17.8% | -100.0% | -38.4% | -100.0% |
Orchard Therapeutics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $32.84 M(-4.8%) |
| Jun 2023 | - | $34.48 M(-7.7%) |
| Mar 2023 | - | $37.37 M(-11.5%) |
| Dec 2022 | $42.24 M(-17.8%) | $42.24 M(-4.8%) |
| Sep 2022 | - | $44.35 M(-7.1%) |
| Jun 2022 | - | $47.72 M(-5.7%) |
| Mar 2022 | - | $50.61 M(-1.5%) |
| Dec 2021 | $51.36 M | $51.36 M(-2.3%) |
| Sep 2021 | - | $52.59 M(-1.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2021 | - | $53.28 M(+36.4%) |
| Mar 2021 | - | $39.05 M(-12.0%) |
| Dec 2020 | $44.37 M(+10.9%) | $44.37 M(-4.3%) |
| Sep 2020 | - | $46.36 M(+12.1%) |
| Jun 2020 | - | $41.36 M(-2.2%) |
| Mar 2020 | - | $42.29 M(+5.7%) |
| Dec 2019 | $40.02 M(>+9900.0%) | $40.02 M(+62.6%) |
| Sep 2019 | - | $24.61 M(+0.4%) |
| Jun 2019 | - | $24.50 M(>+9900.0%) |
| Dec 2018 | $0.00 | $0.00 |
FAQ
- What is Orchard Therapeutics annual long term debt?
- What is the all time high annual long term debt for Orchard Therapeutics?
- What is Orchard Therapeutics annual long term debt year-on-year change?
- What is Orchard Therapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for Orchard Therapeutics?
- What is Orchard Therapeutics quarterly long term debt year-on-year change?
What is Orchard Therapeutics annual long term debt?
The current annual long term debt of ORTX is $42.24 M
What is the all time high annual long term debt for Orchard Therapeutics?
Orchard Therapeutics all-time high annual long term debt is $51.36 M
What is Orchard Therapeutics annual long term debt year-on-year change?
Over the past year, ORTX annual long term debt has changed by -$9.13 M (-17.77%)
What is Orchard Therapeutics quarterly long term debt?
The current quarterly long term debt of ORTX is $32.84 M
What is the all time high quarterly long term debt for Orchard Therapeutics?
Orchard Therapeutics all-time high quarterly long term debt is $53.28 M
What is Orchard Therapeutics quarterly long term debt year-on-year change?
Over the past year, ORTX quarterly long term debt has changed by -$11.51 M (-25.94%)